Outset Medical, Inc.
OM
$3.53
$0.051.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.89% | -6.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.89% | -6.33% | |||
| Cost of Revenue | -6.71% | -8.75% | |||
| Gross Profit | 5.53% | -2.33% | |||
| SG&A Expenses | 12.61% | -6.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.78% | -6.30% | |||
| Operating Income | -11.48% | 6.24% | |||
| Income Before Tax | -11.25% | 5.44% | |||
| Income Tax Expenses | -76.49% | 288.46% | |||
| Earnings from Continuing Operations | -9.27% | 3.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.27% | 3.79% | |||
| EBIT | -11.48% | 6.24% | |||
| EBITDA | -13.15% | 5.78% | |||
| EPS Basic | -9.06% | 4.01% | |||
| Normalized Basic EPS | -11.05% | 5.65% | |||
| EPS Diluted | -9.06% | 4.01% | |||
| Normalized Diluted EPS | -11.05% | 5.65% | |||
| Average Basic Shares Outstanding | 0.19% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.19% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||